癌のサイトカイン療法パイプライン（グローバル市場分析）...市場調査レポートについてご紹介

1. Cancer Cytokines Therapy Market Overview
1.1 Market Overview
1.2 Clinical Pipeline Insight

2. Cancer Cytokine Therapy Clinical Trial Insight by Phase, Country & Target Indications
2.1 Unknown Phase
2.2 Research
2.3 Preclinical
2.4 Clinical
2.5 Phase I
2.6 Phase I/II
2.7 Phase II
2.8 Phase III

3. Marketed Cancer Cytokines Clinical Profile & Patent Analysis

4. Suspended & Discontinued Cancer Cytokines Therapy in Clinical Trial
4.1 No Development Reported
4.2 Discontinued
4.3 Suspended

5. Competitive Landscape
5.1 Altor BioScience
5.2 Biogenomics
5.3 Biosidus
5.4 Chiron Corporation (Novartis)
5.5 Expression Genetics
5.6 IRX Therapeutics
5.7 Philogen
5.8 Roche
5.9 Regulon
5.10 ZymoGenetics

Figure 1-1: Cancer Cytokines Therapy Clinical Pipeline by Phase (%), 2014
Figure 1-2: Cancer Cytokines Therapy Clinical Pipeline by Phase (Number), 2014
Figure 1-3: No Development in Cancer Cytokines Therapy Clinical Pipeline by Phase (%), 2014
Figure 1-4: No Development in Cancer Cytokines Therapy Clinical Pipeline by Phase (Number), 2014
Figure 1-5: Discontinued Cancer Cytokines Therapy Clinical Pipeline by Phase (%), 2014
Figure 1-6: Discontinued Cancer Cytokines Therapy Clinical Pipeline by Phase (Number), 2014
Figure 1-7: Suspended Cancer Cytokines Therapy Clinical Pipeline by Phase (%), 2014
Figure 1-8: Suspended Cancer Cytokines Therapy Clinical Pipeline by Phase (Number), 2014
Figure 5-1: Expression Genetics Clinical Pipeline
Figure 5-2: Philogen Clinical Pipeline

Following Information For Each Drug Profile is Covered in More than 200 Tables in Report:

• Drug Profile Overview
• Active Indication
• Phase of Development
• Country for Clinical Trial
• Owner / Originator/ Licensee/Collaborator
• Administrative Route
• Drug Class